Pay in 4 interest-free payments of $12.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
It does not have any significant activity against 205 other kinases
protein synthesis attenuation
It inhibits HDAC3 with IC50 of 289 nM
and enables repeated photoactivation of motor behaviors in wild-type zebrafish and mice
HCI-2509 (SP2509) - Reversible LSD1 Inhibitor. CAS# 1423715-09-6 054 It does not have anyHCI 2509 (also named as SP2509 or LSD1 C12) , CAS No. 1423715 09 6, is a highly potent, specific, and reversible Lysine Specific Demethylase 1 (LSD1) inhibitor. It inhibits LSD1 in biochemical assay with an IC50 ~13 nM, and has no activity against monoamine oxidase proteins MAO A and MAO B (>300 M). HCI 2509 is a non competitive inhibitor to bind LSD1, changes its solution dynamics in a manner distinct from TCP. It has minimal inhibition of CYPs and
US$ 724.00
US$ 1305.50